[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
March 1985

Hereditary Warfarin Resistance: Investigation of a Rare Phenomenon

Author Affiliations

From the Departments of Hematology (Drs Alving and Barr) and Biochemistry (Dr Strickler), Walter Reed Army Institute of Research. Washington, DC; Hematology Service, Walter Reed Army Medical Center, Washington, DC (Dr Knight); and the Department of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, Md (Drs Berenberg and Peck).

Arch Intern Med. 1985;145(3):499-501. doi:10.1001/archinte.1985.00360030147025

• A 57-year-old black woman required a daily dosage of 50 mg of warfarin sodium to maintain her prothrombin time in a therapeutic range. The central volume of distribution and clearance of warfarin were normal for this patient. These findings, combined with the patient's requirement for plasma warfarin levels four times greater than those usually required to achieve adequate anticoagulation, indicated that the relative resistance was due to altered pharmacodynamics of warfarin. The only child of the propositus, a daughter, showed a similar relative resistance, confirming that this family is the third to be reported with hereditary resistance to warfarin.

(Arch Intern Med 1985;145:499-501)